EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H23ClFN3O.2HCl |
| Net Charge | 0 |
| Average Mass | 460.808 |
| Monoisotopic Mass | 459.10472 |
| SMILES | CCN(CC)CCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21.Cl.Cl |
| InChI | InChI=1S/C21H23ClFN3O.2ClH/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23;;/h5-10,13H,3-4,11-12,14H2,1-2H3;2*1H |
| InChIKey | ZIIJJOPLRSCQNX-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Flurazepam hydrochloride (CHEBI:5129) is a benzodiazepine (CHEBI:22720) |
| Synonyms | Source |
|---|---|
| Flurazepam hydrochloride | KEGG COMPOUND |
| Dalmane | KEGG COMPOUND |
| Manual Xrefs | Databases |
|---|---|
| D00695 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| CAS:1172-18-5 | KEGG COMPOUND |